Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity
The founders of Faber came to know one another as senior professionals in the rapidly evolving biopharmaceutical industry of the early 2000s. Having worked together in one of the strongest in-house transactional law departments then existing in biopharma, each of the founders had pragmatic business focus, experience in strategy leadership and deep substantive knowledge.
Their collective breadth of experience would allow them to create a law firm uniquely capable of immediately offering a range of transactional and advisory services tailored for the specific needs of biopharmaceutical companies and institutions.
With their varied in-house experiences, the founders also knew how entities built around scientific developments in biotechnology and biopharmaceuticals worked best, what their specific needs for transactional assistance were, where challenges might arise, and how they might evolve in a high risk, high reward environment.
From its inception, the Firm valued the complementary roles of lawyers and non-lawyer contracts specialists in biopharma companies. In-house legal departments in small and large organizations have and continue to leverage the role of experienced contracts specialists to achieve transactional goals.
The Firm sought to offer a similar valuation proposition as an external resource by having experienced contracts specialists, working under lawyer supervision, as part of its professional team. In particular, contracts specialists have permitted Faber to provide cost-efficient services for those agreements mostly commonly used in the industry that are frequently template-based and implemented on a high-throughput basis, but that often contain critical IP and risk allocation terms that are aggressively negotiated by vendors, clinical study sites, and other counterparties..
The use of contracts of specialists is another way the Firm has effectively aligned the way it provides services to the way a biopharma client is best able to achieve transactional value in a cost-effective way.
It remains a central principle for the Firm to deliver advice that draws on its experience in a manner that can be right sized to where a client is today, while keeping in mind where they want to be tomorrow.
From its earliest days, our lawyers and contracts specialists worked with client leaders to expand understanding and sensitivity to topics beyond the leaders’ immediate expertise to achieve valuable transactional results that encompass a wide range of relevant issues.